{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:16:50Z","timestamp":1776334610250,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ2\/03065"],"award-info":[{"award-number":["2018\/31\/B\/NZ2\/03065"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.trim.2024.102084","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:52:55Z","timestamp":1720540375000},"page":"102084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study"],"prefix":"10.1016","volume":"85","author":[{"given":"Sylwia","family":"Bia\u0142y","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagoda","family":"Siemaszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Sobczyk-Kruszelnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Fidyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Solarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Nasi\u0142owska-Adamska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrycja","family":"Skowro\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bieniaszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Tomaszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz W.","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Bogunia-Kubik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.trim.2024.102084_bb0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2024.102084_bb0010","first-page":"1390041","article-title":"Hematopoietic stem cell transplantation: back to the future","volume":"11","author":"Editorial","year":"2024","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.trim.2024.102084_bb0015","doi-asserted-by":"crossref","first-page":"1320692","DOI":"10.3389\/fmed.2023.1320692","article-title":"Acute graft versus host disease 1976-2020: reduced incidence and predictive factors","volume":"10","author":"Di Francesco","year":"2024","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.trim.2024.102084_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.578314","article-title":"New approaches for the treatment of chronic graft- versus-host disease: current status and future directions","volume":"11","author":"Saidu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102084_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.569381","article-title":"Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications","volume":"11","author":"Annaloro","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102084_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation.V2012.1.265.3800160","article-title":"Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge","volume":"2012","author":"Marr","year":"2012","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"6871","key":"10.1016\/j.trim.2024.102084_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.trim.2024.102084_bb0040","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.trim.2024.102084_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12755","article-title":"Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B","volume":"89","author":"Wang","year":"2019","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"10.1016\/j.trim.2024.102084_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109699","article-title":"Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment","volume":"36","author":"Banerjee","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.trim.2024.102084_bb0055","doi-asserted-by":"crossref","first-page":"3836942","DOI":"10.1155\/2019\/3836942","article-title":"TIM-3 and TIM-1 could regulate Decidual \u03b3\u03b4TCR bright T cells during murine pregnancy","volume":"2019","author":"N\u00f6renberg","year":"2019","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.trim.2024.102084_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.1010591","article-title":"Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes","volume":"91","author":"Zhang","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.trim.2024.102084_bb0065","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2024.102084_bb0070","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2217\/imt.12.126","article-title":"Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors","volume":"4","author":"Patel","year":"2012","journal-title":"Immunotherapy"},{"issue":"5853","key":"10.1016\/j.trim.2024.102084_bb0075","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.trim.2024.102084_bb0080","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.trim.2024.102084_bb0085","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity [published correction appears in J Exp Med. 2011 Jun 6;208(6):1331]","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trim.2024.102084_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2013.00449","article-title":"Tim-3: an activation marker and activation limiter of innate immune cells","volume":"4","author":"Han","year":"2013","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.trim.2024.102084_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2009.01.019","article-title":"Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses","volume":"15","author":"Gill","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.trim.2024.102084_bb0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2024.102084_bb0105","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.946365","article-title":"Reversal of natural killer cell exhaustion by TIM-3 blockade","volume":"3","author":"Gallois","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trim.2024.102084_bb0110","doi-asserted-by":"crossref","first-page":"1267774","DOI":"10.3389\/fimmu.2023.1267774","article-title":"NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?","volume":"14","author":"Bjorgen","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.trim.2024.102084_bb0115","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.1501522","article-title":"NK cell functional impairment after allogeneic hematopoietic stem cell transplantation is associated with reduced levels of T-bet and Eomesodermin","volume":"195","author":"Simonetta","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2024.102084_bb0120","doi-asserted-by":"crossref","first-page":"1889822","DOI":"10.1080\/2162402X.2021.1889822","article-title":"TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients","volume":"10","author":"Rakova","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trim.2024.102084_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/gene.2011.75","article-title":"TIM polymorphisms\u2014genetics and function","volume":"12","author":"Lee","year":"2011","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.trim.2024.102084_bb0130","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181235","article-title":"TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects","volume":"38","author":"Liu","year":"2018","journal-title":"Biosci. Rep."},{"issue":"21","key":"10.1016\/j.trim.2024.102084_bb0135","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.3390\/ijms21218318","article-title":"TIM-3 genetic variants are associated with altered clinical outcome and susceptibility to gram-positive infections in patients with Sepsis","volume":"21","author":"Mewes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.trim.2024.102084_bb0140","doi-asserted-by":"crossref","first-page":"2329024","DOI":"10.1080\/16078454.2024.2329024","article-title":"TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia","volume":"29","author":"Alqahtani","year":"2024","journal-title":"Hematology"},{"issue":"5529","key":"10.1016\/j.trim.2024.102084_bb0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1059431","article-title":"Haplotype variation and linkage disequilibrium in 313 human genes [published correction appears in science 2001 Aug 10;293(5532):1048]","volume":"293","author":"Stephens","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.trim.2024.102084_bb0150","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.3390\/ijms24032042","article-title":"The Variations\u2019 in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis","volume":"24","author":"Andrzejczak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.trim.2024.102084_bb0155","first-page":"667","volume":"56","author":"Sun","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.trim.2024.102084_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606721","article-title":"Immune checkpoint molecules-inherited variations as markers for Cancer risk","volume":"11","author":"Wagner","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2024.102084_bb0165","first-page":"644","article-title":"TIM-3 Rs10515746 (a\/C) and Rs10053538 (C\/a) gene polymorphisms and risk of multiple sclerosis","volume":"45","author":"Yaghoobi","year":"2016","journal-title":"Iran. J. Public Health"},{"issue":"8","key":"10.1016\/j.trim.2024.102084_bb0170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.humimm.2011.04.007","article-title":"T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status","volume":"72","author":"Song","year":"2011","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2024.102084_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211146","article-title":"TIM family gene polymorphism and susceptibility to rheumatoid arthritis: systematic review and meta- analysis","volume":"14","author":"Razi","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.trim.2024.102084_bb0180","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI45138","article-title":"Allograft rejection is restrained by short-lived TIM-3+PD- 1+Foxp3+ Tregs","volume":"122","author":"Gupta","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.trim.2024.102084_bb0185","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.4049\/jimmunol.0903435","article-title":"TIM-3: a novel regulatory molecule of alloimmune activation","volume":"185","author":"Boenisch","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2024.102084_bb0190","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/TP.0b013e3181b47f25","article-title":"Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice","volume":"88","author":"He","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2024.102084_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trim.2008.01.008","article-title":"Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts","volume":"19","author":"Wang","year":"2008","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2024.102084_bb0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2024.102084_bb0205","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","article-title":"A novel soluble form of Tim-3 associated with severe graft-versus-host disease","volume":"19","author":"Hansen","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2024.102084_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41409-023-02168-0","article-title":"Galectin-3 predicts acute GvHD and overall mortality post reduced intensity Allo-HCT: a BMT-CTN biorepository study","volume":"59","author":"McCarthy","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2024.102084_bb0215","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm-120888","article-title":"Soluble T cell immunoglobulin and mucin Domain-3 (sTIM-3) predicts graft-versus-host disease (GVHD) in Iranian allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Nalini","year":"2022","journal-title":"Int J Cancer Manag."},{"issue":"3","key":"10.1016\/j.trim.2024.102084_bb0220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/blood-2011-10-387977","article-title":"Contrasting acute graft-versus-host disease effects of Tim-3\/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells","volume":"120","author":"Veenstra","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trim.2024.102084_bb0225","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3389\/fimmu.2019.03158","article-title":"Preliminary results of a combined score based on sIL2-R\u03b1 and TIM-3 levels assayed early after hematopoietic transplantation","volume":"10","author":"Leotta","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2024.102084_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/16078454.2020.1738097","article-title":"Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients","volume":"25","author":"Yegin","year":"2020","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.trim.2024.102084_bb0235","first-page":"400","volume":"43","author":"Cao","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.trim.2024.102084_bb0240","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.jtct.2023.05.021","article-title":"Phase II, open-label clinical trial of urinary-derived human chorionic gonadotropin\/epidermal growth factor for life-threatening acute graft- versus-host disease","volume":"29","author":"Holtan","year":"2023","journal-title":"Transplant Cell Ther."},{"issue":"3","key":"10.1016\/j.trim.2024.102084_bb0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcyt.2021.09.008","article-title":"Response to extracorporeal photopheresis therapy of patients with steroid-refractory\/\u2212resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells","volume":"24","author":"Ni","year":"2022","journal-title":"Cytotherapy"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742400100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742400100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:48:16Z","timestamp":1728406096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742400100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S096632742400100X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102084","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102084"}}